Impact of burn injury on hepatic TGF-β1 expression and plasma TGF-β1 levels

Background: The liver plays a critical regulatory role in the acute inflammatory response to injury, although the mechanisms of this regulation are not well understood, transforming growth factor-β 1 (TGF-β 1 ) is induced after burn injury and may contribute to an inhibitory or fatal effect on hepatocytes. We investigated the association over time between plasma concentration of TGF-β 1 , expression of TGF-β 1 m-RNA in liver tissue, and histologic analysis of liver apoptosis after burn injury. Methods: Male BALB/c mice were anesthetized and randomized to receive 0% (sham), moderate (approximately 25%) (M), or large (approximately 50%) (L) body surface area full-thickness contact burn, followed by resuscitation and analgesia. Animals were killed over a time course from 15 minutes to 24 hours after burn injury, and liver tissue and peripheral blood were collected. Plasma levels of TGF-β 1 (nanograms per milliliter) were measured by enzyme-linked immunosorbent assay. TGF-β 1 m-RNA was extracted from liver and measured by reverse transcription-polymerase chain reaction. Histology of liver apoptosis was examined after fixation and staining with TdT-mediated dUTP nick-end labeling (TUNEL) method. Results: The plasma concentration of TGF-β 1 in burn group L was significantly increased at 4 hours after burn when compared with sham and M burn groups. This rise in plasma TGF-β 1 was preceded by an increase in hepatic TGF-β 1 m-RNA expression at 30 minutes, 1, 2, and 4 hours after burn in the L group. Histologic analysis found greater hepatocyte death in the L group than in the M group at 8 hours after burn. Conclusion: The levels of induced TGF-β 1 and TGF-β 1 m-RNA after L burn injury are higher and peak earlier than after M burn injury. Elevated TGF-β 1 may be associated with cell death in hepatocytes. The TGF-β 1 rise may be associated with hepatocyte injury and systemic response to massive burn.

[1]  D. Brenner,et al.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.

[2]  M Chrétien,et al.  Pro‐protein convertase gene expression in human breast cancer , 1997, International journal of cancer.

[3]  K. Meert,et al.  Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression. , 1996, The Journal of trauma.

[4]  S. Werner,et al.  Transforming Growth Factors 1, 2, and 3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound Healing (*) , 1996, The Journal of Biological Chemistry.

[5]  S. Kobayashi,et al.  Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. , 1995, Journal of clinical pathology.

[6]  D M Bissell,et al.  Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. , 1995, The Journal of clinical investigation.

[7]  D. Schiffer,et al.  A Study of Apoptosis in Normal and Pathologic Nervous Tissue After In situ End‐Labeling of DNA Strand Breaks , 1994, Journal of neuropathology and experimental neurology.

[8]  F. Ponchel,et al.  Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. , 1994, Cancer research.

[9]  W. Bursch,et al.  Apoptosis is induced by transforming growth factor‐β1 within 5 hours in regressing liver without significant fragmentation of the DNA , 1993, Hepatology.

[10]  A. Wyllie,et al.  Apoptosis (the 1992 Frank Rose Memorial Lecture). , 1993, British Journal of Cancer.

[11]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.

[12]  R. Pollard,et al.  Transforming growth factor- in the regulation of the immune response , 1992 .

[13]  F. Weiner,et al.  Increased transforming growth factor-β1 gene expression in human liver disease , 1992 .

[14]  S. Wahl Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. , 1992, Journal of clinical immunology.

[15]  H. Stein,et al.  Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.

[16]  J. Massagué,et al.  Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function , 1991, Molecular and cellular biology.

[17]  J. Azizkhan,et al.  Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts , 1991, Molecular and cellular biology.

[18]  W. Bursch,et al.  Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. , 1991, Cancer research.

[19]  S. Thorgeirsson,et al.  Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[20]  S. Thorgeirsson,et al.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.

[21]  A. Boobis,et al.  Mechanisms of cell death. , 1989, Trends in pharmacological sciences.

[22]  M. Czaja,et al.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.

[23]  M. A. Hayes,et al.  Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta. , 1987, Cancer research.

[24]  R. Coffey,et al.  Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. , 1987, The Journal of clinical investigation.

[25]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[26]  S. Thorgeirsson,et al.  Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. , 1986, Cancer research.

[27]  H. Moses,et al.  Inhibition of DNA Synthesis in rat hepatocytes by Platelet-derived Type β Transforming Growth Factor , 1986 .

[28]  T. Nakamura,et al.  Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. , 1985, Biochemical and biophysical research communications.

[29]  W. Bursch,et al.  Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. , 1984, Carcinogenesis.

[30]  J F Kerr,et al.  Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.

[31]  V. Paradis,et al.  Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. , 1995, Journal of hepatology.

[32]  W. Bursch,et al.  Cell death by apoptosis and its protective role against disease. , 1992, Trends in pharmacological sciences.

[33]  M. Czaja,et al.  Expression of Tumor Necrosis Factor-α and Transforming Growth Factor-β1 in Acute Liver Injury , 1989 .

[34]  W. Russell Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. , 1988, Journal of cellular physiology.

[35]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.